FREDERICK, Md., May 11, 2023 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc.® (“TOMI”) (NASDAQ: TOMZ), a global company specializing in disinfection and decontamination solutions, today announced the addition of Technimount System (“Technimount”) as an exclusive distributor selling capital equipment to the emergency medical services market throughout Canada.
Technimount System is a highly reputable manufacturer and distributor that provides products to a variety of industries, including emergency medical services, hospitals, and military environments. With an extensive network of customers, Technimount has established itself as a trusted source for high-quality products and services. As part of its commitment to providing top-of-the-line solutions, Technimount System has recently signed an exclusive agreement with TOMI, a leading provider of disinfection and decontamination solutions. Technimount has adopted TOMI's SteraMist system as its preferred disinfection solution, allowing Technimount to offer its customers a more effective and efficient way of disinfecting their environments.
"We are thrilled to announce our exclusive partnership with TOMI and the adoption of SteraMist as our preferred disinfection system. At Technimount System, we are committed to providing our customers with the most advanced solutions on the market, and SteraMist's cutting-edge technology is a perfect fit for our portfolio,” states Carl Bouchard, President and CEO of Technimount System. “This partnership represents a significant step forward in our efforts to help keep our customers' environments safe and healthy. We look forward to working closely with TOMI and leveraging their expertise to continue to meet the evolving needs of our customers."
As part of their commitment to this new partnership and their strong belief in the value of our brand, Technimount System has made a significant capital investment to acquire SteraMist mobile units. These units will allow its customers to quickly and easily deploy SteraMist's disinfection capabilities in a variety of settings, helping to keep their environments safe.
Elissa J. (E.J.) Shane, the COO of TOMI, commented, "This partnership solidifies SteraMist's position as a top provider of advanced disinfection solutions. By collaborating with Technimount System, we have strategically positioned SteraMist to gain a foothold in the Canadian market. This partnership represents a significant international development for TOMI, and in addition we are looking forward to future customer developments as we utilize Technimount System's extensive network of customers in the emergency services market.”
TOMI™ Environmental Solutions, Inc.: Innovating for a safer world®
TOMI™ Environmental Solutions, Inc. (NASDAQ: TOMZ) is a global decontamination and infection prevention company, providing environmental solutions for disinfection through the manufacturing, sales and licensing of its premier Binary Ionization Technology ® (BIT™) platform. Invented under a defense grant in association with the Defense Advanced Research Projects Agency (DARPA) of the U.S. Department of Defense, BIT™ solution utilizes a low percentage hydrogen peroxide as its only active ingredient and uses patented ionized Hydrogen Peroxide (iHP™) technology in all SteraMist systems to create superior disinfection. TOMI products are designed to service a broad spectrum of use sites, including, but not limited to, hospitals and medical facilities, biosafety labs, pharmaceutical facilities, commercial and office buildings, schools, restaurants, meat and produce processing facilities, and police and fire departments.
For additional information, please visit http://www.tomimist.com/ or contact us at info@tomimist.com
About Technimount System
Technimount System is a Canadian company that incorporates engineering, manufacturing and commercialization divisions dedicated to serving the Healthcare industry with its divisions of EMS and Medical Sales, including an office in Orlando, FL, USA.
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995
This press release contains forward-looking statements that are based on current expectations, estimates, forecasts and projections of future performance based on management’s judgment, beliefs, current trends, and anticipated product performance. These forward-looking statements include, without limitation, statements relating to SteraMist’s opportunities in the new partnership. Forward-looking statements involve risks and uncertainties that may cause actual results to differ materially from those contained in the forward-looking statements. Forward-looking statements involve a number of risks and uncertainties, all of which are difficult or impossible to predict accurately and many of which are beyond our control. As such, our actual results could differ materially and adversely from those expressed in any forward-looking statements as a result of various factors. Important factors that could affect our performance and cause results to differ materially from management’s expectations are described in the section entitled “Risk Factors,” in our Annual Report on Form 10-K and other SEC filings. These factors include: our history of losses that may prevent us from achieving profitability in the future; our lack of long-term customer contracts and our inability to rely on our sales history or backlog as an indicator of our future sales; that we are subject to a variety or risks associated with doing business internationally; our success in business depends on our ability to adequately protect our intellectual property; and that our stock price is volatile and there is a limited market for our shares. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, level of activity, performance, or achievements. You should not place undue reliance on these forward-looking statements. All information provided in this press release is as of today’s date, unless otherwise stated, and we undertake no duty to update such information, except as required under applicable law.
INVESTOR RELATIONS CONTACT:
John Nesbett/Jennifer Belodeau
IMS Investor Relations
